Epigenetic regulation of myofibroblast differentiation and extracellular matrix production in nasal polyp-derived fibroblasts

Clinical and Experimental Allergy

Volumn 42, Issue 6, 2012, Pages 872-882

  Cho, J S ^a   Moon, Y M ^a   Park, I H ^a   Um, J Y ^a   Moon, J H ^a   Park, S J ^a   Lee, S H ^a   Kang, H J ^a   Lee, Heung Man ^a,b  

^a Korea University College of Medicine   (South Korea)

^b Korea University College of Medicine   (South Korea)

Author keywords

Extracellular matrix; Histone deacetylase; Myofibroblasts; Nasal polyp derived fibroblasts; Nasal polyposis; TGF 1; Trichostatin A

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ALPHA SMOOTH MUSCLE ACTIN; COLLAGEN TYPE 1; CONTRACTILE PROTEIN; HISTONE DEACETYLASE 2; HISTONE H3; HISTONE H4; KI 67 ANTIGEN; RECOMBINANT TRANSFORMING GROWTH FACTOR BETA1; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD7 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; TRICHOSTATIN A;

ARTICLE; CELL DIFFERENTIATION; CELL ISOLATION; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; CHRONIC RHINOSINUSITIS; CLINICAL ARTICLE; COLLAGEN GEL CONTRACTION ASSAY; COLLAGEN SYNTHESIS; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; ENZYME INHIBITION; EPIGENETICS; EXTRACELLULAR MATRIX; FIBROBLAST; GENE EXPRESSION; GENE INACTIVATION; GENE SILENCING; HISTONE ACETYLATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MYOFIBROBLAST; NOSE POLYP; NOSE POLYP DERIVED FIBROBLAST; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; SIRCOL SOLUBLE COLLAGEN ASSAY; WESTERN BLOTTING;

ACETYLATION; ACTINS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; EPIGENESIS, GENETIC; EXTRACELLULAR MATRIX; FIBROBLASTS; GENE EXPRESSION REGULATION; HISTONE DEACETYLASE 2; HISTONE DEACETYLASE INHIBITORS; HISTONES; HUMANS; HYDROXAMIC ACIDS; MYOFIBROBLASTS; NASAL POLYPS; PHOSPHORYLATION; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84863817342     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/j.1365-2222.2011.03931.x     Document Type: Article

References (32)

1. Pawankar R. Nasal polyposis: an update: editorial review. Curr Opin Allergy Clin Immunol 2003; 3:1-6.
2. Nakagawa T, Yamane H, Nakai Y, Shigeta T, Takashima T, Takeda Z. Comparative assessment of cell proliferation and accumulation of extracellular matrix in nasal polyps. Acta Otolaryngol Suppl 1998; 538:205-8.
3. Wang QP, Escudier E, Roudot-Thoraval F, Abd-Al Samad I, Peynegre R, Coste A. Myofibroblast accumulation induced by transforming growth factor-beta is involved in the pathogenesis of nasal polyps. Laryngoscope 1997; 107:926-31.
4. Serpero L, Petecchia L, Sabatini F et al. The effect of transforming growth factor (TGF)-beta1 and (TGF)-beta2 on nasal polyp fibroblast activities involved upper airway remodeling: modulation by fluticasone propionate. Immunol Lett 2006; 105:61-7.
5. Massague J. The transforming growth factor-beta family. Annu Rev Cell Biol 1990; 6:597-641.
6. Nonaka M, Pawankar R, Fukumoto A, Yagi T. Heterogeneous response of nasal and lung fibroblasts to transforming growth factor-beta 1. Clin Exp Allergy 2008; 38:812-21.
7. Blobe GC, Schiemann WP, Lodish HF. Role of transforming growth factor beta in human disease. N Engl J Med 2000; 342:1350-8.
8. Bartram U, Speer CP. The role of transforming growth factor beta in lung development and disease. Chest 2004; 125:754-65.
9. Watelet JB, Claeys C, Perez-Novo C, Gevaert P, Van Cauwenberge P, Bachert C. Transforming growth factor beta1 in nasal remodeling: differences between chronic rhinosinusitis and nasal polyposis. Am J Rhinol 2004; 18:267-72.
10. Steinke JW, Crouse CD, Bradley D et al. Characterization of interleukin-4-stimulated nasal polyp fibroblasts. Am J Respir Cell Mol Biol 2004; 30:212-9.
11. Barnes PJ, Adcock IM, Ito K. Histone acetylation and deacetylation: importance in inflammatory lung diseases. Eur Respir J 2005; 25:552-63.
12. Bhavsar P, Ahmad T, Adcock IM. The role of histone deacetylases in asthma and allergic diseases. J Allergy Clin Immunol 2008; 121:580-4.
13. Ausio J, Levin DB, De Amorim GV, Bakker S, Macleod PM. Syndromes of disordered chromatin remodeling. Clin Genet 2003; 64:83-95.
14. de Ruijter AJ, van Gennip AH, Caron HN, Kemp S, van Kuilenburg AB. Histone deacetylases (HDACs): characterization of the classical HDAC family. Biochem J 2003; 370:737-49.
15. Barnes PJ. Role of HDAC2 in the pathophysiology of COPD. Annu Rev Physiol 2009; 71:451-64.
16. Noh H, Oh EY, Seo JY et al. Histone deacetylase-2 is a key regulator of diabetes- and transforming growth factor-beta1-induced renal injury. Am J Physiol Renal Physiol 2009; 297: F729-39.
17. Komorowsky C, Ocker M, Goppelt-Struebe M. Differential regulation of connective tissue growth factor in renal cells by histone deacetylase inhibitors. J Cell Mol Med 2009; 13:2353-64.
18. Rombouts K, Niki T, Greenwel P et al. Trichostatin A, a histone deacetylase inhibitor, suppresses collagen synthesis and prevents TGF-beta(1)-induced fibrogenesis in skin fibroblasts. Exp Cell Res 2002; 278:184-97.
19. Ghosh AK, Mori Y, Dowling E, Varga J. Trichostatin A blocks TGF-betainduced collagen gene expression in skin fibroblasts: involvement of Sp1. Biochem Biophys Res Commun 2007; 354:420-6.
20. Sharma A, Mehan MM, Sinha S, Cowden JW, Mohan RR. Trichostatin a inhibits corneal haze in vitro and in vivo. Invest Ophthalmol Vis Sci 2009; 50:2695-701.
21. Niki T, Rombouts K, De Bleser P et al. A histone deacetylase inhibitor, trichostatin A, suppresses myofibroblastic differentiation of rat hepatic stellate cells in primary culture. Hepatology 1999; 29:858-67.
22. Guo W, Shan B, Klingsberg RC, Qin X, Lasky JA. Abrogation of TGF-beta1-induced fibroblast-myofibroblast differentiation by histone deacetylase inhibition. Am J Physiol Lung Cell Mol Physiol 2009; 297:L864-70.
23. Choi JH, Oh SW, Kang MS, Kwon HJ, Oh GT, Kim DY. Trichostatin A attenuates airway inflammation in mouse asthma model. Clin Exp Allergy 2005; 35:89-96.
24. Evans RA, Tian YC, Steadman R, Phillips AO. TGF-beta1-mediated fibroblast-myofibroblast terminal differentiation-the role of Smad proteins. Exp Cell Res 2003; 282:90-100.
25. Strutz F, Zeisberg M, Renziehausen A et al. TGF-beta 1 induces proliferation in human renal fibroblasts via induction of basic fibroblast growth factor (FGF-2). Kidney Int 2001; 59:579-92.
26. Massague J, Seoane J, Wotton D. Smad transcription factors. Genes Dev 2005; 19:2783-810.
27. Hautmann MB, Madsen CS, Owens GK. A transforming growth factor beta (TGFbeta) control element drives TGFbeta-induced stimulation of smooth muscle alpha-actin gene expression in concert with two CArG elements. J Biol Chem 1997; 272:10948-56.
28. Nakao A, Fujii M, Matsumura R et al. Transient gene transfer and expression of Smad7 prevents bleomycin-induced lung fibrosis in mice. J Clin Invest 1999; 104:5-11.
29. Kashiwagi Y, Horie K, Kanno C et al. Trichostatin A-induced TGF-beta type II receptor expression in retinoblastoma cell lines. Invest Ophthalmol Vis Sci 2010; 51:679-85.
30. Sun Y, Liu X, Ng-Eaton E, Lodish HF, Weinberg RA. SnoN and Ski protooncoproteins are rapidly degraded in response to transforming growth factor beta signaling. Proc Natl Acad Sci USA 1999; 96:12442-7.
31. Wotton D, Lo RS, Swaby LA, Massague J. Multiple modes of repression by the Smad transcriptional corepressor TGIF. J Biol Chem 1999; 274:37105-10.
32. Rostkowska-Nadolska B, Kapral M, Mazurek U, Gawron W, Pres K. Co-expression of the TGF-beta1 and TGF- beta2 isoforms in nasal polyps and in healthy mucosa. Postepy Hig Med Dosw (Online) 2007; 61:702-7.